After menopause women change from an estrogen protective milieu, where HCV-mediated inflammation is controlled, to a hepatic proinflammatory state where estrogen levels drop and IL-6 and TNF-α cytokines levels greatly increase possibly increasing the risk of hepatic fibrosis progression. Here, IL6 is linked to Hepatic fibrosis.